SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:liu-182240"
 

Search: id:"swepub:oai:DiVA.org:liu-182240" > Natural History of ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Natural History of Facioscapulohumeral Dystrophy in Children A 2-Year Follow-up

Dijkstra, Jildou N. (author)
Radboud Univ Nijmegen, Netherlands; Radboud Univ Nijmegen, Netherlands
Goselink, Rianne J. M. (author)
Linköpings universitet,Institutionen för biomedicinska och kliniska vetenskaper,Medicinska fakulteten,Region Östergötland, Neurologiska kliniken i Linköping
van Alfen, Nens (author)
Radboud Univ Nijmegen, Netherlands
show more...
de Groot, Imelda J. M. (author)
Radboud Univ Nijmegen, Netherlands
Pelsma, Maaike (author)
Radboud Univ Nijmegen, Netherlands
van der Stoep, Nienke (author)
Leiden Univ, Netherlands
Theelen, Thomas (author)
Radboud Univ Nijmegen, Netherlands; Radboud Univ Nijmegen, Netherlands
van Engelen, Baziel G. M. (author)
Radboud Univ Nijmegen, Netherlands
Voermans, Nicol C. (author)
Radboud Univ Nijmegen, Netherlands
Erasmus, Corrie E. (author)
Radboud Univ Nijmegen, Netherlands
show less...
 (creator_code:org_t)
LIPPINCOTT WILLIAMS & WILKINS, 2021
2021
English.
In: Neurology. - : LIPPINCOTT WILLIAMS & WILKINS. - 0028-3878 .- 1526-632X. ; 97:21, s. E2103-E2113
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Background and Objectives Data on the natural history of facioscapulohumeral dystrophy (FSHD) in childhood are limited and critical for improved patient care and clinical trial readiness. Our objective was to describe the disease course of FSHD in children. Methods We performed a nationwide, single-center, prospective cohort study of FSHD in childhood assessing muscle functioning, imaging, and quality of life over 2 years of follow-up. Results We included 20 children with genetically confirmed FSHD who were 2 to 17 years of age. Overall, symptoms were slowly progressive, and the mean FSHD clinical score increased from 2.1 to 2.8 (p = 0.003). The rate of progression was highly variable. At baseline, 16 of 20 symptomatic children had facial weakness; after 2 years, facial weakness was observed in 19 of 20 children. Muscle strength did not change between baseline and follow-up. The most frequently and most severely affected muscles were the trapezius and deltoid. The functional exercise capacity, measured with the 6-minute walk test, improved. Systemic features were infrequent and nonprogressive. Weakness-associated complications such as lumbar hyperlordosis and dysarthria were common, and their prevalence increased during follow-up. Pain and fatigue were frequent complaints in children, and their prevalence also increased during follow-up. Muscle ultrasonography revealed a progressive increase in echogenicity. Discussion FSHD in childhood has a slowly progressive but variable course over 2 years of follow-up. The most promising outcome measures to detect progression were the FSHD clinical score and muscle ultrasonography. Despite this disease progression, an improvement on functional capacity may still occur as the child grows up. Pain, fatigue, and a decreased quality of life were common symptoms and need to be addressed in the management of childhood FSHD. Our data can be used to counsel patients and as baseline measures for treatment trials in childhood FSHD.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Neurologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Neurology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Neurology (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view